RSC-BMCS/SCI Targeted Protein Degradation 5

One of the most exciting new therapeutic modalities to emerge in the 21st century has been Targeted Protein Degradation (TPD). The targeted protein degradation (TPD) market in 2025 is estimated to be worth between approximately $0.48 billion and $0.65 billion,  Expected to reach anywhere from $3.5 billion to $9.85 billion by 2034 or 2035.

This multidisciplinary meeting aims to present the latest developments in the design, biology, chemistry and ADME in TPD within the general themes of PROTACS (including non-oncology targets), Molecular Glues and non-PROTAC degraders. We aim to highlight the newest in enabling technologies such as computational techniques, Direct to Biology, HT synthesis (click, photochemistry etc) and structural biology methods.

Head to the event page for further details